Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Telomir secures $5.6 million financing as it advances Telomir-Zn into clinical development under an FDA-cleared IND in TNBC.